Elora 10mg
Elora (LY3841136) is a synthetic, long-acting amylin receptor agonist developed for investigational research involving metabolic regulation, appetite signaling, and energy homeostasis. Engineered with increased selectivity toward the amylin-1 receptor (AMY1R), Elora provides researchers with a valuable tool for studying receptor-selective amylin pharmacology, downstream intracellular signaling, and peptide-receptor interactions while minimizing activation of calcitonin receptors under controlled laboratory conditions.
In controlled laboratory environments, Elora is commonly evaluated for its interaction with amylin receptor complexes and the signaling pathways involved in satiety regulation, gastric motility, glucose homeostasis, nutrient sensing, and metabolic adaptation. Investigational applications may include studies involving AMY1R receptor pharmacology, cyclic AMP (cAMP) signaling, central appetite regulation, hypothalamic neurobiology, gastric emptying kinetics, pancreatic hormone interactions, energy expenditure, adipose tissue biology, body composition research, peptide pharmacokinetics, receptor selectivity, and structure-activity relationships. Due to its prolonged biological persistence and receptor specificity, Elora also serves as an important research compound for evaluating next-generation amylin-based therapeutics and combination peptide strategies.
Because of its selective receptor profile and extended duration of action, Elora has become a valuable analytical reagent for laboratory investigations involving metabolic physiology, endocrine signaling, peptide engineering, obesity biology, and long-acting peptide therapeutics. Experimental findings remain dependent upon laboratory design, model selection, and controlled research conditions and should not be interpreted as established therapeutic outcomes.
Supplied in a 10 mg lyophilized presentation, Elora is suitable for analytical and investigational laboratory workflows. Each vial is provided as a white lyophilized powder with a specified purity of ≥99%. Third-party certificates of analysis are published on our Lab Results page for tested compounds and added as testing is completed.
Specifications
Size: 10 mg
Compound Type: Synthetic amylin receptor agonist
Primary Target: Amylin-1 Receptor (AMY1R)
Form: Lyophilized powder
Purity: ≥99% (target specification)
Storage: Store at -20°C away from light and moisture. Reconstitute only under appropriate laboratory conditions using standard research protocols.
Intended Use
This product is supplied strictly for laboratory research purposes only and is intended for use by qualified professionals in controlled scientific environments. It is not for human or animal consumption and is not intended for therapeutic, diagnostic, veterinary, cosmetic, or food use. All handling and use must comply with applicable institutional and regulatory guidelines.
FDA Disclaimer
The statements made on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). Products offered are not intended to diagnose, treat, cure, or prevent any disease. Alamo Peptides operates solely as a supplier of research materials and analytical reagents. We are not a pharmacy, outsourcing facility, or pharmaceutical manufacturer. All products are intended exclusively for research use only. By purchasing, customers acknowledge responsibility for proper handling, use, and compliance with all applicable laws and regulations.
Terms of Sale
All sales are final due to the nature of research materials. Purchasers must be 21 years of age or older. Improper use voids any warranties. Alamo Peptides assumes no liability for misuse or improper application of supplied materials.
